Life science research and clinical diagnostic products manufacturer Bio-Rad Laboratories has acquired AbD Serotec, a division of MorphoSys. Under the transaction, Bio-Rad paid euro 53m in cash to AbD Serotec, which offers over 15,000 ...
Tags: clinical diagnostic products, Bio-Rad Laboratories, AbD Serotec
Germany based MorphoSys has closed the transaction of selling its AbD Serotec segment to Bio-Rad. Transfer of all assets and liabilities of MorphoSys'research and diagnostic antibody segment,the AbD Serotec,in addition to all shares of ...
Tags: shares, AbD Serotec, Bio-Rad, divestment
Bio-Rad Laboratories, a provider of clinical diagnostic products, has purchased Propel Labs' automated sorting flow cytometer. Under the agreement, Bio-Rad will name the new cell sorting system as the S3 Cell Sorter which will provide ...
Bio-Rad Laboratories has unveiled a new Digital Biology Center to develop new products for research and diagnostics markets. The first launched QX100 Droplet Digital PCR system will utilize the droplet partitioning technology to ...
Tags: Bio-Rad Laboratories, Digital Biology Center, PCR system, Bio-Rad Labs
Clinical diagnostic tools manufacturer Bio-Rad Laboratories has agreed to buy AbD Serotec for €53m ($69.7m) in cash. The transaction, signed under the definitive agreement, is subject to certain closing conditions and is expected to ...
Tags: Clinical diagnostic tools, diagnostic tools, antibody, Bio-Rad
Bio-Rad Laboratories has entered into an agreement to purchase a division of MorphoSys, AbD Serotec, for euro 53m. The deal, which is anticipated to complete in January 2013, is subject to certain closing conditions. Bio-Rad life ...
Tags: Bio Rad, Abd Serotec, antibodies, cell sorting
Myriad Genetics and Bio-Rad Laboratories have entered into collaboration agreement to develop new immunoassay kits. Under the agreement, Bio-Rad has gained distribution rights, for research purposes, to the catalog of quantitative ...
Tags: Myriad, Bio-Rad, collaboration agreement, new immunoassay kits
Bio-Rad Laboratories (BIO) and (BIO.B) and the wholly owned subsidiary of Myriad Genetics (MYGN), Myriad RBM, have joined forces to develop and distribute immunoassay kits. As part of the agreement, Myriad RBM will provide Bio-Rad ...
Tags: immunoassay kits, medical research, medical technology